Mobble
Health · Drug development · published 2026-08-12 · via MedPage Today

Safety Warnings Raised for Extended-Release Diazoxide Choline in Prader-Willi Syndrome

Experts warn of potential safety risks with extended-release diazoxide choline (Vykat XR), approved last year for extreme hunger in Prader-Willi syndrome. The concerns highlight the need for careful monitoring.

Read the full article at MedPage Today →
Related stories
Expert panel raises alarm over deaths linked to Neurocrine's Prader-Willi drug · Drug development
Experts Highlight Unequal Type 1 Diabetes Care and Other Health Disparities · Healthcare systems
European regulators revoke Amgen's rare disease drug Tavneos over data concerns · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source. Original headline: “Experts Flag Potential Safety Concerns in New Prader-Willi Drug.” Browse more stories.